20/20 Biolabs, Inc.
AIDX- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- SEC CIK
- 0001139685
No open-market purchases or sales by 20/20 Biolabs, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $297.1K in total; no superinvestor holds it.
Members of Congress who traded AIDX
No member of Congress has reported a trade in 20/20 Biolabs, Inc. since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.